EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: Pilot study



Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: Pilot study



Journal of Gastroenterology 32(2): 141-147



A new dosage formulation consisting of an anticancer drug bound to activated carbon particles was developed for the treatment of digestive cancer in patients in whom operation is contraindicated. The new formulation is designed to distribute higher levels of anticancer drug to the regional lymph nodes and at the injection site compared to distribution of the drug in aqueous solution. In 12 patients with histologically proven carcinoma (7 with superficial esophageal cancer and 5 with early or proper muscle layer-infiltrating gastric cancer), an anticancer drug bound to carbon particles (total dose, 40-100 mg peplomycin or 250-500 mg methotrexate per person) was injected endoscopically into the primary lesions. Eleven of the 12 patients are currently alive, 12-64 months after therapy, or they died without evidence of cancer 12-98 months after the treatment. One patient has remained cancer-free for 32 months after a second course of the new formulation therapy given to treat a recurrence detected 26 months after the first treatment. Endoscopic injection of this new dosage formulation seems to control these digestive cancers in patients in whom operation is contraindicated.

(PDF emailed within 0-6 h: $19.90)

Accession: 008603603

Download citation: RISBibTeXText

PMID: 9085159

DOI: 10.1007/bf02936359



Related references

Endoscopic local injection of anticancer drugs bound to carbon particles for treatment of upper digestive tract cancers--clinical trials. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 24(12): 1668-1671, 1997

Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer--a pilot study. Anti-Cancer Drugs 8(7): 666-670, 1997

Endoscopic local injection of a new drug-delivery format of peplomycin for superficial esophageal cancer: a pilot study. Gastroenterology 104(4): 1037-1043, 1993

Endoscopic local injection of anticancer drugs bound to carbon particles for treatment of advanced rectal cancer, when surgical treatment was contraindicated. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 29(12): 2413-2415, 2002

Local injection of anti-cancer drugs bound to carbon particles for early gastric cancer--a pilot study. Hepato-Gastroenterology 47(32): 575-578, 2000

A pilot study of fiberscopy-guided local injection of anti-cancer drugs bound to carbon particles for control of rectal cancer. Anti-Cancer Drugs 9(4): 363-367, 1998

A new drug-delivery-system of anticancer agents: activated carbon particles adsorbing anticancer agents. In Vivo 1(4): 241-252, 1987

Drug delivery to the posterior segment of the eye IV: theoretical formulation of a drug delivery system for subconjunctival injection. Journal of Ocular Pharmacology and Therapeutics 25(1): 29-37, 2009

Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers. Current Cancer Drug Targets: -, 2018

Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma. Journal of Controlled Release 243: 29-42, 2016

Methotrexate bound to carbon particles used for treating cancers with lymph node metastases in animal experiments and a clinical pilot study. Cancer. 78(10): 2199-2209, 1996

Endoscopic injection of mitomycin adsorbed on carbon particles for advanced esophageal cancer: a pilot study. Endoscopy 36(5): 421-425, 2004

Oral delivery of anticancer drugs III: formulation using drug delivery systems. Drug Discovery Today 18(1-2): 99-104, 2013

Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs-The influence of drug-drug and drug-polymer interactions on drug loading and release properties. International Journal of Pharmaceutics 510(1): 365-374, 2016

A Molecular Study on Drug Delivery System Based on Carbon Nanotube Compared to Silicon Carbide Nanotube for Encapsulation of Platinum-Based Anticancer Drug. Advanced Pharmaceutical Bulletin 8(1): 163-167, 2018